Zdrowie i gospodarka · 29/06/1998

FDA Corrects Final Rule on Clinical Investigators' Financial Disclosure

The Food and Drug Administration (FDA) is correcting a final rule that was published with an error, requiring drug and device sponsors to disclose the compensation and financial interests of clinical investigators conducting certain clinical studies, as mandated by the February 2, 1998, rule (63 FR 5233).